ATE157546T1 - Verwendung von anabolika zur herstellung eines arzneimittels zur behandlung von seniler dementia und der alzheimerschen krankheit - Google Patents
Verwendung von anabolika zur herstellung eines arzneimittels zur behandlung von seniler dementia und der alzheimerschen krankheitInfo
- Publication number
- ATE157546T1 ATE157546T1 AT88100233T AT88100233T ATE157546T1 AT E157546 T1 ATE157546 T1 AT E157546T1 AT 88100233 T AT88100233 T AT 88100233T AT 88100233 T AT88100233 T AT 88100233T AT E157546 T1 ATE157546 T1 AT E157546T1
- Authority
- AT
- Austria
- Prior art keywords
- disease
- levels
- hormones
- alzheimer
- senile dementia
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Endocrinology (AREA)
- Physiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Steroid Compounds (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP88100233A EP0324037B1 (de) | 1988-01-11 | 1988-01-11 | Verwendung von Anabolika zur Herstellung eines Arzneimittels zur Behandlung von seniler Dementia und der Alzheimerschen Krankheit |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE157546T1 true ATE157546T1 (de) | 1997-09-15 |
Family
ID=8198634
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT88100233T ATE157546T1 (de) | 1988-01-11 | 1988-01-11 | Verwendung von anabolika zur herstellung eines arzneimittels zur behandlung von seniler dementia und der alzheimerschen krankheit |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0324037B1 (de) |
AT (1) | ATE157546T1 (de) |
DE (1) | DE3856017T2 (de) |
ES (1) | ES2109914T3 (de) |
GR (1) | GR3025576T3 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5149786A (en) * | 1989-10-12 | 1992-09-22 | Chiron Corporation | Dopamine releasing protein and antibody |
IT9041720A1 (it) * | 1990-10-26 | 1992-04-27 | Fidia Spa | Metodo per la diagnosi del parkinson idiopatico |
WO1994022469A1 (en) * | 1993-04-02 | 1994-10-13 | Ohio University | Enhancement of learning and/or memory by a human somatotropin |
SE9804064D0 (sv) * | 1998-11-25 | 1998-11-25 | A & Science Invest Ab | Medicinal product and method for treatment of conditions affecting neural stem cells or progenitor cells |
ATE353653T1 (de) * | 2003-07-29 | 2007-03-15 | Acme Srl | Verwendung von stanozolol zur herstellung von entzündungshemmenden und antidegenerativen arzneimitteln |
-
1988
- 1988-01-11 DE DE3856017T patent/DE3856017T2/de not_active Expired - Fee Related
- 1988-01-11 ES ES88100233T patent/ES2109914T3/es not_active Expired - Lifetime
- 1988-01-11 AT AT88100233T patent/ATE157546T1/de not_active IP Right Cessation
- 1988-01-11 EP EP88100233A patent/EP0324037B1/de not_active Expired - Lifetime
-
1997
- 1997-12-03 GR GR970403226T patent/GR3025576T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP0324037B1 (de) | 1997-09-03 |
DE3856017D1 (de) | 1997-10-09 |
EP0324037A1 (de) | 1989-07-19 |
GR3025576T3 (en) | 1998-03-31 |
ES2109914T3 (es) | 1998-02-01 |
DE3856017T2 (de) | 1998-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Hoyer et al. | Predominant abnormality in cerebral glucose utilization in late-onset dementia of the Alzheimer type: a cross-sectional comparison against advanced late-onset and incipient early-onset cases | |
Hunter et al. | Neuropathological findings in three cases of persistent dyskinesia following phenothiazine medication | |
Tuite et al. | Dopa‐responsive parkinsonism phenotype of Machado‐Joseph disease: confirmation of 14q CAG expansion | |
De Volder et al. | Decreased glucose utilization in the striatum and frontal lobe in probable striatonigral degeneration | |
EP0276723B1 (de) | Vorläuferprotein des APC-Polypeptids, dafür codierende DNA und diagnostische Verwendung der DNA und des Proteins | |
Gruen et al. | Growth hormone responses to hypoglycemia in postmenopausal depressed women | |
Weiskrantz et al. | A study of forgetting in amnesic patients | |
EP0293974B1 (de) | Verwendung von Sulfomucopolysacchariden zur therapeutischen Behandlung von Krankheiten des Alzheimertyps | |
Gibb et al. | Pathological report of four patients presenting with cranial dystonias | |
Sachar et al. | Human growth hormone response to levodopa: Relation to menopause, depression, and plasma dopa concentration | |
Linkowski et al. | The 24-hour profile of plasma prolactin in men with major endogenous depressive illness | |
Korenke et al. | Glyceroltrioleate/glyceroltrierucate therapy in 16 patients with X-chromosomal adrenoleukodystrophy/adrenomyeloneuropathy: effect on clinical, biochemical and neurophysiological parameters | |
ATE157546T1 (de) | Verwendung von anabolika zur herstellung eines arzneimittels zur behandlung von seniler dementia und der alzheimerschen krankheit | |
Bierich et al. | New observations on midline defects: coincidence of anophthalmos, microphthalmos and cryptophthalmos with hypothalamic disorders | |
Jennekens-Schinkel et al. | A clinical trial with desglycinamide arginine vasopressin for the treatment of memory disorders in man | |
Wyatt | The dopamine hypothesis: Variations on a theme | |
JP2850128B2 (ja) | 老化度測定方法 | |
Tattersall | A history of growth hormone | |
Mastropaolo et al. | EEG studies in 22 children with sulphatide lipidosis (metachromatic leucodystrophy) | |
Longatti et al. | The CSF myelin basic protein in pediatric hydrocephalus | |
Bezard et al. | Glutamatergic compensatory mechanisms in experimental parkinsonism | |
Paine et al. | Atypical Variants of the ‘Ataxia Telangiectasia’Syndrome: Report of Two Cases, Including One with Apparent Dominant Inheritance | |
Christensen et al. | Plasma growth hormone in acromegalic patients | |
US5065748A (en) | Method of diagnosing growth hormone disorders employing somatostatin and growth hormone releasing hormone | |
Hare et al. | Acute porphyria: Two cases with autopsy reports |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |